2018-2025 @ DJ Technologies

Structure Therapeutics CEO Envisions ‘Best-in-Class’ Weight-Loss Drug Amid Soaring Success


Structure Therapeutics (GPCR) said Monday patients who took a high dose of its GLP-1-targeted obesity treatment lost up to 15.3% more body weight than placebo recipients. Structure Therapeutics stock rose sharply in early trades. The results support plans to begin a Phase 3 study in mid-2026, Structure said in a news release. Chief Executive Raymond Stevens said patients who took…



Source link

Posted

in

by

Dinesh

Tags:

, , , , , , , ,

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by